These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2047564)

  • 21. Contribution of metabolites to the route- and time-dependent hepatic effects of di-(2-ethylhexyl)phthalate in the rat.
    Pollack GM; Shen DD; Dorr MB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):176-81. PubMed ID: 2913270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes.
    Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK
    Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of endosulfan and dietary vitamin A on rat hepatic drug metabolising enzymes.
    Sriram K; Misra UK
    Acta Vitaminol Enzymol; 1983; 5(4):213-8. PubMed ID: 6424426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism.
    Bachmann KA; Nunlee M; Martin M; Schwartz J; Jauregui L; Forney RB
    Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats.
    Nadai M; Sekido T; Matsuda I; Li W; Kitaichi K; Itoh A; Nabeshima T; Hasegawa T
    J Pharm Pharmacol; 1998 Aug; 50(8):871-9. PubMed ID: 9751451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of single-sample clearance estimates to probe hepatic drug metabolism in rats. IV. A model for possible application to phenotyping xenobiotic influences on human drug metabolism.
    Bachmann KA
    Xenobiotica; 1989 Dec; 19(12):1449-59. PubMed ID: 2618092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I.
    Bachmann KA; Yang C; Jahn D; Schwartz J
    Xenobiotica; 1988 Feb; 18(2):151-9. PubMed ID: 3131969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable inhibition of human hepatic drug metabolizing enzymes by disulfiram.
    Freundt KJ
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):323-30. PubMed ID: 669879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of long-term fenfluramine treatment on drug-metabolism in rat.
    Arvela P; Kärki NT; Nieminen L; Bjondahl K; Möttönen M
    Experientia; 1973 Apr; 29(4):454-5. PubMed ID: 4708346
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction of anticancer drugs with hepatic monooxygenase enzymes.
    Le Blanc GA; Waxman DJ
    Drug Metab Rev; 1989; 20(2-4):395-439. PubMed ID: 2680389
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic drug-metabolizing enzymes in lung tumor-bearing rats.
    Dogra SC; Khanduja KL; Sharma RR
    Biochem Pharmacol; 1985 Sep; 34(17):3190-3. PubMed ID: 4038331
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
    Sakai H; Kobayashi S; Hamada K; Iida S; Akita H; Tanaka E; Uchida E; Yasuhara H
    Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of fenfluramine on certain enzymes and on skin and amniotic cells in tissue culture.
    Sapeika N
    Postgrad Med J; 1975; 51 Suppl 1():85-7. PubMed ID: 1219685
    [No Abstract]   [Full Text] [Related]  

  • 36. Selectivity of cholestyramine treatment on hepatic mixed function oxidase activity.
    Bachmann K; Schwartz J; Forney R; Sherman G; Jauregui L
    Pharmacology; 1984; 29(3):128-41. PubMed ID: 6483959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro biotransformation of antipyrine, lignocaine and propranolol in the liver of rats with turpentine-induced inflammation.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Nov; 39(11):883-6. PubMed ID: 2892910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of hexobarbitone and antipyrine in DOCA-hypertensive rats.
    Ben-Zvi Z; Hreash F; Kaplanski J
    J Pharm Pharmacol; 1991 May; 43(5):349-52. PubMed ID: 1680178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nifedipine on hepatic drug oxidation.
    Dickinson TH; Egan JM; Abernethy DR
    Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.